Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Beijing Aosaikang Pharmaceutical

Market Cap: CN¥19.4b

Beijing Aosaikang Pharmaceutical Co., Ltd.

Zealand Pharma

Market Cap: DKK 30.9b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €212.7m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Rein Therapeutics

Market Cap: US$27.8m

A biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States.

Summit Therapeutics

Market Cap: US$15.1b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

Grown Rogue International

Market Cap: CA$149.7m

A craft cannabis company, focuses on premium flower and flower-derived products.

COMPASS Pathways

Market Cap: US$543.0m

Operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States.

Dottikon ES Holding

Market Cap: CHF 4.1b

Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries worldwide.

Cessatech

Market Cap: DKK 195.1m

A pharmaceutical company, develops and commercializes medicines for the treatment of pediatric acute pain in Denmark.

Perspective Therapeutics

Market Cap: US$236.9m

Develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States.

Sana Biotechnology

Market Cap: US$888.4m

A biotechnology company, focuses on utilizing engineered cells as medicines in the United States.

Neuphoria Therapeutics

Market Cap: US$23.4m

A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia.

Zhengye Biotechnology Holding

Market Cap: US$142.2m

Engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China.

OncoZenge

Market Cap: SEK 77.7m

A pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden.

Diamyd Medical

Market Cap: SEK 1.5b

Develops precision medicine therapies for the treatment of autoimmune diabetes.

Aytu BioPharma

Market Cap: US$16.7m

A pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally.

Rezolute

Market Cap: US$796.4m

A late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.

ProQR Therapeutics

Market Cap: US$218.1m

A biotechnology company, focuses on the discovery and development of novel therapeutic medicines.

Diaceutics

Market Cap: UK£137.5m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

Titan Pharmaceuticals

Market Cap: US$5.4m

Does not have significant operations.

Antibiotice

Market Cap: RON 1.7b

Produces and sells medicinal products in Romania and internationally.

Eli Lilly

Market Cap: US$641.5b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

TScan Therapeutics

Market Cap: US$101.0m

A clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States.

Gain Therapeutics

Market Cap: US$62.2m

A biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia.

Bio-Rad Laboratories

Market Cap: US$7.4b

Manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.

Captor Capital

Market Cap: CA$1.6m

Engages in the retail sale of cannabis products in the United States.

Genfit

Market Cap: €155.9m

A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.

Cybin

Market Cap: US$147.7m

A clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.

BeOne Medicines

Market Cap: US$36.2b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Repligen

Market Cap: US$6.8b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Rize Oncology

Market Cap: US$12.1m

A biopharmaceutical company, focuses on the development of precision gene editing for human therapeutics applications.

Changchun BCHT Biotechnology

Market Cap: CN¥8.9b

Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally.

Keymed Biosciences

Market Cap: HK$20.7b

A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China and internationally.

Sigachi Industries

Market Cap: ₹14.6b

Manufactures and sells microcrystalline cellulose and cellulose powder worldwide.

Gulf Pharmaceutical Industries P.S.C

Market Cap: د.إ1.5b

Manufactures and sells medicines, drugs, and various other types of pharmaceutical, cosmetic, and medical compounds in United Arab Emirates, other GCC countries, and internationally.

Shenzhen Hepalink Pharmaceutical Group

Market Cap: CN¥15.9b

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.